HMT, led by Partner Paul Read, Director Corin Briault-Hutter and Manager Josh Valentin undertook financial due diligence for Ethos Partners (‘Ethos’) on their partnership with Labyrinth Dental, one of the UK’s leading dental laboratory groups. Based in Birmingham, Labyrinth Dental is the fourth largest full-service dental laboratory in the UK. Labyrinth Dental brings together eight […]
HMT advised Bay Tree Private Equity on their investment in Medicare Insourcing Services Limited, a leading provider of clinical insourcing services to the NHS. Founded in 2018, Medicare is a leading provider of clinical insourcing services to the NHS, specialising in practitioner-led diagnostic imaging, primarily ultrasound. The business partners with NHS Trusts to deliver additional […]
HMT advised Ethos Partners on their investment in Bray Group, a long-established UK manufacturer of medical products. Founded in 1857 and based in Farringdon, Oxfordshire, Bray began as a family business over a century ago. Today, it has grown into a leading manufacturer and supplier of medical products, specialising in caustics and pessaries. Bray operates […]
HMT LLP advised Maven Capital Partners on their investment in Gen inCode, a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease. Founded in 2018, Gen inCode has developed a range of patented DNA risk assessment products which utilise AI, bioinformatics and a globally recognised clinical evidence base to provide predictive […]
HMT LLP advised specialist pharmaceutical biotech company Biotherapy Services Ltd on their Series A fundraising. Foresight VCT invested £3 million to support the growth of the business supplemented by further investment from existing and new private investors. BTS is a clinical stage, Biopharmaceutical company developing and delivering novel autologous regenerative therapies, currently in clinical development […]
HMT LLP advised Maven Capital Partners on their investment in anti-cancer drugs manufacturer ADC Biotechnology.
HMT advised Premier Research Group on the AIM flotation and on four subsequent acquisitions.
